cgp 12177 has been researched along with Ventricular Dysfunction, Left in 1 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsukamoto, T | 1 |
| Morita, K | 1 |
| Naya, M | 1 |
| Inubushi, M | 1 |
| Katoh, C | 1 |
| Nishijima, K | 1 |
| Kuge, Y | 1 |
| Okamoto, H | 1 |
| Tsutsui, H | 1 |
| Tamaki, N | 1 |
1 other study available for cgp 12177 and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Decreased myocardial beta-adrenergic receptor density in relation to increased sympathetic tone in patients with nonischemic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Carbon Radioisotopes; Cardiomyopathies; Female; Heart; Heart Failure; H | 2007 |